First Author | Carr MS | Year | 2006 |
Journal | Mamm Genome | Volume | 17 |
Issue | 1 | Pages | 5-13 |
PubMed ID | 16416086 | Mgi Jnum | J:104484 |
Mgi Id | MGI:3612026 | Doi | 10.1007/s00335-005-0092-1 |
Citation | Carr MS, et al. (2006) Expression of a modified H19 RNA does not cause embryonic lethality in mice. Mamm Genome 17(1):5-13 |
abstractText | The imprinted H19 gene produces a noncoding RNA of unknown function. Targeted and transgenic mouse mutations have shown that this RNA can be deleted and overexpressed without adverse effect. Yet one mutation of the H19 gene displayed an embryonic lethal phenotype in the mouse-the expression of an RNA modified by a short insertion near the 5' end of the transcript (H19(Xba) allele). Expression of this RNA in transgenic mice conferred lethality at day 14 of development. The potential for this mutant to elucidate the function of the H19 RNA supported further investigation of the H19(Xba) phenotype. Since all H19(Xba) transgenic founders died as embryos, an experiment was designed to generate H19(Xba)-expressing mice that could be maintained as an established line. This strategy took advantage of the maternal-specific expression of H19, passing an H19(Xba) knockin allele silently through males and transferring it to females only to generate animals for study. Surprisingly, H19(Xba) knockin mice are fully viable, whether the H19(Xba) allele is inherited paternally or maternally. Experiments to reproduce the original transgene-based lethality were also performed and yielded live-born transgene-expressing animals. These data demonstrate that, contrary to published reports, expression of the H19(Xba) RNA does not cause embryonic lethality in mice. |